Cite
HARVARD Citation
Regan, C. et al. (2015). The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Regan, C. et al. (2015). The transfer of genetically engineered lymphocytes in melanoma patients: a Phase I dose escalation study. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].